<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01910051</url>
  </required_header>
  <id_info>
    <org_study_id>OBDM-01</org_study_id>
    <nct_id>NCT01910051</nct_id>
  </id_info>
  <brief_title>Explorative Assessment of Biomarkers in Overweight and Obese Subjects</brief_title>
  <official_title>Explorative Assessment of Biomarkers Indicative of Insulin Resistance and Prediabetes in Overweight and Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Profil Institut für Stoffwechselforschung GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Profil Institut für Stoffwechselforschung GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rationale for this trial is to apply a simple and minimally strenuous pre-screening
      approach prior to performing more extensive trial-specific screening and
      baseline-characterization activities in the resulting pre-selected population of subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pre-screening assessments are designed to characterize the metabolic risk profile /
      prediabetic status in an unselected population of overweight and obese volunteers, aiming to
      pre-select high risk and prediabetic subjects as a target population who may specifically
      profit from primary diabetes intervention (prevention) strategies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>anthropometric measures and metabolic biomarkers indicative of prediabetes</measure>
    <time_frame>Day one</time_frame>
    <description>One blood sample taken on day 1 of the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intra-subject and inter-subject variability of analyzed biomarkers</measure>
    <time_frame>within one month</time_frame>
    <description>Several circulating markers including the traditionally used fasting serum insulin and fasting plasma glucose as well as an oral glucose tolerance test may serve as indicators of prediabetes. Importantly, these parameters show considerable intra-individual short-term variability. The assessments will therefore be repeated three times within a one month period to determine intra-subject variability of the analyzed parameters under the conditions that apply to the trial site and experimental conditions.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>the correlation between anthropometric data, medical history, and biomarkers with regard to metabolic risk</measure>
    <time_frame>up to 3 years</time_frame>
    <description>assessment of study data at the end of the study</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Prediabetes</condition>
  <arm_group>
    <arm_group_label>Generally healthy</arm_group_label>
    <description>Generally healthy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 diabetes mellitus</arm_group_label>
    <description>Type 2 diabetes mellitus</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Generally healthy or Type 2 Diabetes mellitus
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese and overweight subjects

          -  Considered generally healthy

        Exclusion Criteria:

          -  Clinically significant acute illness within 2 weeks before study procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leona Plum-Mörschel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Profil Institut für Stoffwechselforschung GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elke Gurschke</last_name>
    <phone>+4921314018</phone>
    <phone_ext>411</phone_ext>
    <email>regulatory@profil.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Profil Institut für Stoffwechselforschung GmbH</name>
      <address>
        <city>Neuss</city>
        <zip>41460</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elke Gurschke</last_name>
      <phone>+4921314018</phone>
      <phone_ext>411</phone_ext>
      <email>regulatory@profil.com</email>
    </contact>
    <investigator>
      <last_name>Leona Plum-Mörschel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2013</study_first_submitted>
  <study_first_submitted_qc>July 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2013</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

